Potential mechanisms underlying the effect of hepatocyte growth factor on liver injury in short bowel syndrome model rats

This rat model study investigates how hepatocyte growth factor (HGF) may protect against liver injury in short bowel syndrome by modulating autophagy and apoptosis pathways. HGF treatment reduced hepatic steatosis and inflammation, with effects mediated through caspase 9 and autophagy markers Rubicon and p62.